Michael Khela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Khela has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Carol Lee Wilkinson
Division of Developmental Medicine, Boston Children's Hospital, Boston, MA
1 shared publication Cigdem Gelegen
Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
1 shared publicationCraig A. Erickson
Division of Child and Adolescent Psychiatry, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication- Francesca A. Chaloner
UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publication - Jordan E. Norris
Department of Psychology, University of Oklahoma, Norman, USA
1 shared publication Lauren E. Ethridge
Department of Psychology, University of Oklahoma, Norman, USA
1 shared publication
Latest Publications
- Open Access
- 9 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice
Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of Fmr1 -/y mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of Fmr1 in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA B receptors by Arbaclofen in wild-type than Fmr1 -/y mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.
- 9 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice
Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of Fmr1 -/y mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of Fmr1 in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA B receptors by Arbaclofen in wild-type than Fmr1 -/y mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.